These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 709935

  • 1. Short-term effects of varying doses of 1 alpha-hydroxyvitamin D3 on blood and urine chemistry and calcium absorption of osteoporotic patients.
    Lindholm TS, Sevastikoglou JA, Lindgren U.
    Clin Orthop Relat Res; 1978 Sep; (135):226-31. PubMed ID: 709935
    [Abstract] [Full Text] [Related]

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 3. Interim report on treatment of osteoporotic patients with 1 alpha-hydroxyvitamin D3 and calcium.
    Lindholm TS, Sevastikoglou JA, Lindgren U.
    Clin Orthop Relat Res; 1978 Sep; (135):232-40. PubMed ID: 709936
    [Abstract] [Full Text] [Related]

  • 4. Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: effect of age and dietary calcium.
    Gallagher JC, Riggs BL, Eisman J, Hamstra A, Arnaud SB, DeLuca HF.
    J Clin Invest; 1979 Sep; 64(3):729-36. PubMed ID: 468987
    [Abstract] [Full Text] [Related]

  • 5. Comparison of effects of 1 alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 in man.
    Brickman AS, Coburn JW, Friedman GR, Okamura WH, Massry SG, Norman AW.
    J Clin Invest; 1976 Jun; 57(6):1540-7. PubMed ID: 932193
    [Abstract] [Full Text] [Related]

  • 6. Results of long-term treatment of osteoporosis with 1 alpha-hydroxyvitamin D3 and calcium.
    Lindholm TS, Eriksson S, Lindholm TC.
    Ital J Orthop Traumatol; 1984 Jun; 10(2):187-201. PubMed ID: 6432736
    [Abstract] [Full Text] [Related]

  • 7. Role of vitamin D, its metabolites, and analogs in the management of osteoporosis.
    Bikle DD.
    Rheum Dis Clin North Am; 1994 Aug; 20(3):759-75. PubMed ID: 7984788
    [Abstract] [Full Text] [Related]

  • 8. Effect of estrogen on calcium absorption and serum vitamin D metabolites in postmenopausal osteoporosis.
    Gallagher JC, Riggs BL, DeLuca HF.
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1359-64. PubMed ID: 6255005
    [Abstract] [Full Text] [Related]

  • 9. [Efficiency of calcium and vitamin D3 in the treatment of steroid osteoporosis in patients with hormone dependent bronchial asthma].
    Ememl'ianov AV, Shevelev SE, Murzin BA, Amosov VI.
    Ter Arkh; 1999 Dec; 71(11):68-9. PubMed ID: 10626343
    [Abstract] [Full Text] [Related]

  • 10. Intestinal calcium absorption in exogenous hypercortisonism. Role of 25-hydroxyvitamin D and corticosteroid dose.
    Klein RG, Arnaud SB, Gallagher JC, Deluca HF, Riggs BL.
    J Clin Invest; 1977 Jul; 60(1):253-9. PubMed ID: 874087
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Alterations in serum and urine parameters reflecting bone turnover in uremic patients during treatment with 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3.
    Mortensen BM, Gordeladze JO, Lyngdal PT, Aarseth HP, Gautvik KM.
    Miner Electrolyte Metab; 1993 Jul; 19(2):78-85. PubMed ID: 8377728
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [The efficacy of combined use of 1 alpha-hydroxyvitamin D3 with calcium supplements in the treatment of osteoporosis].
    Yoshikawa S, Ohno A, Moro K, Matsumoto M, Nemoto H, Seki H, Kaneko N, Hosokawa O, Ishijima H.
    Nihon Seikeigeka Gakkai Zasshi; 1988 Aug; 62(8):723-32. PubMed ID: 3235892
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of 1alpha-hydroxyvitamin D3 on serum calcium and immunoreactive parathyroid hormone in patients with chronic renal insufficiency.
    Pietrek J, Kokot F, Kuska J.
    Int Urol Nephrol; 1978 Aug; 10(2):153-60. PubMed ID: 700946
    [Abstract] [Full Text] [Related]

  • 18. A low dose regime of 1 alpha hydroxyvitamin D3 in the management of senile osteoporosis: a pilot study.
    Cohen HN, Farrah D, Fogelman I, Goll CC, Beastall GH, McIntosh WB, Fletcher M, Boyle IT.
    Clin Endocrinol (Oxf); 1980 Jun; 12(6):537-42. PubMed ID: 7398099
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Vitamin D metabolism and the response to 1,25-dihydroxycholecalciferol in Osteoporosis.
    Davies M, Mawer EB, Adams PH.
    J Clin Endocrinol Metab; 1977 Aug; 45(2):199-208. PubMed ID: 195972
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.